Valuation (31%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -1.51 | 49.50 |
PEG Ratio (TTM) | 0.05 | 4.50 |
P/S Ratio (TTM) | 1.26 | 13.78 |
P/B Ratio (TTM) | 1.87 | 7.34 |
P/FCF Ratio (TTM) | -11.64 | 229.30 |
Price to 5YR AVG Earnings Ratio | -3.84 | 105.54 |
Price to 5YR AVG FCF Ratio | -29.92 | 97.57 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -82.77% | 6.72% |
ROE (TTM) | -95.11% | 11.28% |
Net Profit Margin (TTM) | -83.02% | -0.16% |
ROIC 5YR AVG | -14.41% | 11.39% |
Growth (0%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -153.06% | -89.39% | -121.77% |
Revenue | -3.73% | -2.56% | -2.17% |
Net Income | -152.98% | -91.15% | -124.51% |
Cash Flow | -135.65% | -1.06% | -7,220.42% |
Health (21%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 2.25 | 3.26 |
Quick Ratio (TTM) | 1.41 | 2.48 |
D/E Ratio (TTM) | N/A | 0.51 |
Interest Coverage (TTM) | -29.18 | 39.67 |
Piotroski F-Score | 4 | 6 |
Altman Z-Score | N/A | 27.26 |
LTL to 5YR AVG FCF | -0.32 | 4.14 |
Shares Outstanding Growth 5YR AVG | 1.40% | 0.91% |